Sign in
HQL Stock Price, Chart, Stats & News
Tekla Life Sciences Investors
Save
HQL chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 30.80% |
Operating margin | 286.92% |
Pretax margin | 286.92% |
Net margin | 286.92% |
Effective tax rate | – |
ROA | 16.61% |
ROE | 18.82% |
D/E | – |
Interest coverage ratio | – |
HQL valuation
P/E | 2.70x |
P/S | 15.53x |
P/B | 0.90x |
P/CF | -199.72x |
P/FCF | -199.72x |
P/OCF | -199.72x |
PEG | 0.01x |
EV multiple | 5.41x |
About
Tekla Life Sciences Investors, a closed-ended equity mutual fund, is expertly managed by Tekla Capital Management LLC. This U. S.-domiciled fund, which commenced operations on February 20, 1992, and was formerly known as H&Q Life Sciences Investors, seeks investment opportunities in publicly traded companies worldwide.
Similar securities
Based on sector and market capitalization
Report issue